US EditionState of Texas Sues Bristol-Myers Squibb and Sanofi for Deceptive Marketing of Blood Thinner Plavix
Texas alleges Bristol-Myers Squibb and Sanofi hid Plavix's ineffectiveness for many patients, wasting billions in Medicaid funds, affecting millions including minority groups.
- On Nov. 20, 2025, the State of Texas filed a lawsuit in the 71st District Court of Harrison County, naming Bristol-Myers Squibb Company and Sanofi-Aventis U.S. as defendants.
- The complaint alleges Plavix had diminished or no effect for Black, East Asian, and Pacific Islander patients due to genetic factors, violating the Texas Deceptive Trade Practices-Consumer Protection Act and Texas Healthcare Program Fraud Prevention Act.
- Documents show Texas alleges the companies knew or should have known since 1998 but added no warning until 2010, with a $700 million settlement in Hawaii, and Mark Lanier said `for over a decade, these pharmaceutical companies put profits over people`.
- As a result, millions of Texans were improperly prescribed Plavix and taxpayer-funded healthcare programs like Texas Medicaid wasted billions, the state says.
- Attorneys described the suit as an important step toward accountability and said Texans' trust was betrayed, with McKool Smith bringing more than 130 trial lawyers to the case.
25 Articles
25 Articles
Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug - Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY), Sanofi (NASDAQ:SNY)
Texas Attorney General Ken Paxton escalated his campaign against major drugmakers this week, filing a new lawsuit accusing Sanofi SA (NASDAQ:SNY) and Bristol-Myers Squibb Co (NYSE:BMY) of concealing critical information about the effectiveness of their blood-thinning medication Plavix. According to the complaint, the companies marketed Plavix—also sold generically as clopidogrel bisulfate—as a reliable treatment to prevent heart attacks, strokes…
State of Texas Sues Bristol-Myers Squibb and Sanofi for Deceptive Marketing of Blood Thinner Plavix
DALLAS, Nov. 20, 2025 /PRNewswire/ -- McKool Smith and The Lanier Law Firm, along with Texas Attorney General Ken Paxton, have filed a lawsuit on behalf of the State of Texas against pharmaceutical giants Bristol-Myers Squibb Company and several Sanofi…
State of Texas Sues Bristol-Myers Squibb and Sanofi for Deceptive Marketing of Blood Thinner Plavix
DALLAS, Nov. 20, 2025 /PRNewswire/ -- McKool Smith and The Lanier Law Firm, along with Texas Attorney General Ken Paxton, have filed a lawsuit on behalf of the State of Texas against pharmaceutical giants Bristol-Myers Squibb Company and several Sanofi…
State of Texas Sues Bristol-Myers Squibb and Sanofi for Deceptive Marketing of Blood Thinner Plavix
DALLAS, Nov. 20, 2025 /PRNewswire/ -- McKool Smith and The Lanier Law Firm, along with Texas Attorney General Ken Paxton, have filed a lawsuit on behalf of the State of Texas against pharmaceutical giants Bristol-Myers Squibb Company and several Sanofi…
State of Texas Sues Bristol-Myers Squibb and Sanofi for Deceptive Marketing of Blood Thinner Plavix
DALLAS, Nov. 20, 2025 /PRNewswire/ -- McKool Smith and The Lanier Law Firm, along with Texas Attorney General Ken Paxton, have filed a lawsuit on behalf of the State of Texas against pharmaceutical giants Bristol-Myers Squibb Company and several Sanofi…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
